LONDON--(BUSINESS WIRE)--Pensions First Analytics, a market leading financial technology business, today announced that the United States Patent and Trademark Office has issued US Patent 8,566,206 covering its web-based platform for the risk management and reporting of pension plan assets, liabilities and risk.
Pensions First Analytics delivers its proprietary technology through PFaroe® which allows in depth analysis of assets, liabilities and risk on a consistent basis through multiple risk-lenses.
Timothy Lyons, Chairman of PensionsFirst Analytics, commented:
"…..as the pioneer of an integrated web-based approach to measuring and managing risk for defined benefit pension plans, like many technology companies we are keen to protect IP in which we have made a considerable investment. However, having secured a business process patent covering web-based reporting of pension plan assets, liabilities and risk, we intend to take a constructive approach to working with others interested in licensing our IP …”
About PensionsFirst Analytics
PensionsFirst Analytics is a financial technology company that provides intuitive, user-friendly risk analytics and business intelligence solutions. Initially targeted towards the UK, where it is currently used by 157 pension plans with over £107 Billion of liabilities, PFaroe® is now also establishing a growing presence in the US. For more information please go to www.pensionsfirst.com
Statement under the Private Securities Litigation Reform Act:
With the exception of any historical information contained in this release, this release may contain forward-looking statements that involve risk and uncertainties that may individually or mutually impact the matters herein described, including but not limited to, product acceptance, the ability to continually obtain increased orders of its products, the ability to meet installation goals, economic, competitive, governmental impacts, whether pending patents will be granted or defendable, validity of intellectual property and patents, the ability to license patents and the ability to commercialize development, as well as other factors that may be identified in the future.